News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News NY Valves 2024 Long-term Mortality After TAVI Lower With DOACs vs VKAs Todd Neale June 06, 2024
News Daily News Another DOAC Fails in the Setting of Mechanical Heart Valves Todd Neale September 28, 2022
News Daily News Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes Todd Neale July 04, 2022
News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News CRT 2021 DOAC Use Increasing in Patients With Bioprosthetic Heart Valves Todd Neale March 08, 2021
News Conference News ACC 2020 Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair L.A. McKeown April 07, 2020
News Conference News ACC 2020 A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI Todd Neale March 29, 2020
News Daily News Long-term Watchman Data Reassure: CAP and CAP2 Registries Michael O'Riordan December 02, 2019
News Daily News Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests Todd Neale January 09, 2019
News Opinion Conversations in Cardiology Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC? November 16, 2018